Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Trinity Capital (NASDAQ: TRIN) has announced a $30 million growth capital commitment to Silk Technologies, a software-defined cloud storage provider. Silk's platform specializes in enhancing cloud applications and databases performance while optimizing cloud resource usage and data management costs.
The company has demonstrated significant growth, doubling its revenue over the past two years through new customer acquisitions. The funding will support Silk's operational scaling and growth initiatives, particularly as AI drives increased demand for data processing capabilities. The company's solutions target various sectors including finance, healthcare, insurance, and retail industries.
Trinity Capital (NASDAQ: TRIN) has committed $12.5 million in growth capital to Upward Health, an in-home healthcare provider specializing in 24/7 whole-person care for high-risk patients. The funding is part of a larger debt financing package that includes an additional $7.5 million from Comerica Bank, alongside a Series C fundraise led by Heritage Group and Blue Venture Fund.
Upward Health, ranked 7th on the 2023 Inc. 5000 list and 6th in 2024 among fastest-growing private U.S. companies, will use the capital to fund growth initiatives, expand coverage area, and refine their care model. The company partners with health plans and risk-bearing entities to improve health outcomes and quality of life for high-need patients.
Trinity Capital (Nasdaq: TRIN), a leading alternative asset manager, announced a record funding of $1.2 billion in investments for 2024. The company originated $1.6 billion in new commitments throughout the year.
In the fourth quarter of 2024, Trinity funded $297 million, which included $190 million in secured loans, $96 million in equipment financings, and $11 million in warrant and equity investments. The company also originated $411 million in new commitments during the same period.
For the full year, Trinity's investments included $887 million in secured loans, $304 million in equipment financings, and $38 million in warrant and equity investments. The company funded $968 million to 39 new portfolio companies and $245 million to 28 existing portfolio companies. Proceeds from repayments and exits totaled $808 million, including $314 million from early debt repayments and refinancings.
CEO Kyle Brown expressed satisfaction with the year's performance, highlighting the company's unique business structure and value creation for investors and partners.
Trinity Capital (NASDAQ: TRIN) has committed $50 million in equipment financing to Form Energy, a technology company developing innovative multi-day energy storage systems. Form Energy specializes in iron-air battery technology capable of storing electricity for 100 hours at competitive costs. The financing will support equipment purchases for Form Energy's first high-volume battery manufacturing facility in Weirton, West Virginia. This commitment follows Form Energy's recent $455 million Series F fundraise led by T. Rowe Price. The company aims to enhance energy system reliability and sustainability through its cost-effective storage solutions.
Trinity Capital (Nasdaq: TRIN) has declared a quarterly cash dividend of $0.51 per share for Q4 2024, maintaining the same level as Q3 2024. This marks the company's 20th consecutive quarter of consistent or increased dividends. The dividend will be paid on January 15, 2025, to shareholders of record as of December 31, 2024.
The company aims to distribute 90% to 100% of its taxable quarterly income through four quarterly dividends to maintain its regulated investment company tax status. Trinity may also pay supplemental dividends to distribute approximately all annual taxable income in the year earned or carry over excess taxable income for future dividend payments.
Trinity Capital Inc. (Nasdaq: TRIN) has announced an expansion of its credit facility to $600 million, representing a $90 million increase from the previous $510 million commitment. The expansion was executed under the existing accordion feature, which allows for maximum commitments of up to $690 million. The additional funding was provided by a diversified bank syndicate comprising 13 participants, led by KeyBank N.A. The increased facility enhances Trinity's ability to grow its platform while maintaining substantial liquidity.
Trinity Capital (NASDAQ: TRIN) has committed $20 million in growth capital to Steno, a tech-enabled legal support and court reporting services provider. The funding is part of Steno's larger $46 million fundraise in May 2024. Steno offers tech-based solutions to streamline litigation processes, including court-reporting services, remote deposition software, and deferred payment options.
Founded by a trial attorney, computer engineer, and entrepreneur, Steno has demonstrated strong performance with 119% year-over-year growth. The company plans to use the capital to scale its business and enhance product offerings, including solutions like Transcript Genius.
Trinity Capital Inc. (NASDAQ: TRIN) has committed $40 million in growth capital to Impress, a leading European orthodontic chain specializing in invisible aligners. The funding is part of a larger $117 million funding round and will support Impress's expansion plans, including opening 20 new clinics across Europe. Based in Barcelona, Impress operates a network of clinics serving over 250,000 patients annually and has recently acquired DrSmile to strengthen its market position in Europe.
Trinity Capital (Nasdaq: TRIN) announced its board has authorized a $30 million stock repurchase program running until November 7, 2025. The company may repurchase its common stock in the open market, subject to Rule 10b-18 constraints. The board initiated this program believing macroeconomic pressures may cause stock undervaluation relative to company performance and peers. The repurchases will comply with the Investment Company Act of 1940. While Trinity hasn't yet started repurchasing shares, management can now act when deemed advantageous to shareholders.
Trinity Capital (TRIN) reported strong Q3 2024 financial results with record total investment income of $61.8 million, up 33.2% year-over-year, and record net investment income of $29.4 million ($0.54 per share). The company achieved a 16.2% return on average equity and maintained a net asset value of $756.8 million ($13.13 per share). Total gross investment commitments reached $629.2 million, with $459.0 million funded across new and existing portfolio companies. The company's total platform assets under management increased to $2.0 billion, up 54% year-over-year, marking its 19th consecutive quarter of consistent or increased regular dividend.